The partnership between Reeve Waud and Bill Mixon for a $100 million healthcare supply chain platform demonstrates the culmination of three decades of investment advancement at Waud Capital Partners. From a single-person operation in 1993 to a $4.6 billion healthcare-focused private equity powerhouse, Reeve Waud has pioneered systematic approaches to healthcare services investing that have influenced industry practices and generated sustained returns across multiple market cycles.
Bill Mixon’s partnership demonstrates how Reeve Waud’s investment methodology has advanced from opportunistic growth investing to systematic platform building through executive partnerships and comprehensive operational support.
Early Healthcare Investment Development (1993-2010)
Waud Capital Partners began with a broad middle-market growth focus, targeting companies requiring $75-200 million in equity investment across multiple sectors. Reeve Waud’s early investment philosophy emphasized operational improvement and growth rather than financial engineering, an approach that proved prescient as healthcare services markets became increasingly complex and regulation-intensive.
Founding of Acadia Healthcare in 2005 marked a pivotal moment in Reeve Waud’s healthcare investment development. Rather than acquiring an existing behavioral health provider, Waud Capital Partners created Acadia as a startup platform, providing growth capital and guidance to build one of the nation’s largest behavioral hospital systems from inception.
“I had confidence in the opportunity to partner with exceptional executives and build exciting and profitable companies,” Reeve Waud reflected on the firm’s early approach to healthcare platform development.
Acadia Healthcare success, culminating in a 2011 IPO, demonstrated the potential for creating significant value through systematic platform building in healthcare services. Reeve Waud continues to serve as Chairman of Acadia’s board of directors, illustrating his long-term commitment to the businesses he helps create.
Specialization and Scaling Methodology (2010-2020)
Following the Acadia Healthcare breakthrough, Reeve Waud refined Waud Capital Partners’ investment focus to concentrate on healthcare and software/technology sectors where the firm could develop deep expertise and systematic value creation capabilities. This specialization enabled more effective due diligence, operational support, and guidance across portfolio companies.
The firm’s buy-and-build methodology emerged during this period, with healthcare platform investments typically undertaking 10+ add-on acquisitions during hold periods to achieve scale and operational efficiency.. This systematic approach to platform building generated average revenue growth of 400% for realized investments, establishing Waud Capital Partners as a preferred partner for healthcare services consolidation.
Major exits during this period included Center for Vein Restoration, which expanded from 11 clinics to 44 centers across eight states under Waud Capital’s ownership. The CEO noted that Reeve Waud’s team “shared my vision of building a first-class vein treatment business” and provided exceptional guidance for scaling operations.
Fund size growth reflected investor confidence in Waud Capital Partners’ healthcare investment approach, with Fund III raising $487 million in 2011 and Fund IV reaching $1.05 billion in 2016—more than double the previous fund’s size.
Executive-First Campaign Development (2020-Present)
The current phase of Waud Capital Partners’ advancement emphasizes executive-first campaigns where proven healthcare leaders are recruited before platform development begins. This approach reduces execution risk by ensuring operational expertise is embedded from inception while providing executive partners with comprehensive institutional support for growth execution.
GI Alliance investment exemplified this methodology, with Waud Capital Partners partnering with physician leadership to build the largest gastroenterology practice management platform in the United States. The company achieved a $2.2 billion valuation at exit after just four years under Waud Capital ownership.
Recent executive partnerships including Brad Staley for medical supply and device services, Steve Jakubcanin for home care and post-acute services, and now Bill Mixon for healthcare supply chain services demonstrate the systematic nature of Reeve Waud’s executive recruitment across healthcare subsectors.
“The partnership with Bill is another example of Waud Capital’s executive-first campaign approach and commitment to support accomplished executive leaders with the full ecosystem of resources to execute transformative growth strategies in large, growing markets,” said Kyle Lattner, Partner at Waud Capital.
Comprehensive Platform Support Infrastructure
The advancement of Waud Capital Partners under Reeve Waud’s leadership includes development of comprehensive support capabilities that extend beyond traditional private equity capital provision. The firm’s “ecosystem” approach includes dedicated business development teams that proactively identify acquisition targets, portfolio operations professionals who optimize performance across platform companies, and advisory resources that guide long-term value creation.
This institutional infrastructure enables executive partners like Bill Mixon to focus on operational excellence while leveraging Waud Capital’s capabilities for deal sourcing, due diligence, integration, and development. The comprehensive support model reflects Reeve Waud’s recognition that successful healthcare services platforms require sustained operational and support rather than traditional financial sponsor relationships.
Bill Mixon’s partnership, backed by over $100 million in equity capital, provides access to this full ecosystem of resources for building what both partners envision as an industry-leading healthcare supply chain platform across home distribution, specialty distribution, outsourced provider equipment services, and chronic care management.
Healthcare Services Investment Leadership
Three decades of investment advancement have positioned Reeve Waud as a healthcare services private equity pioneer whose systematic approaches have influenced industry practices and generated sustained returns across multiple market cycles. The progression from opportunistic growth investing to executive-first campaign development demonstrates continuous innovation and adaptation to changing healthcare market dynamics.
From its headquarters in downtown Chicago, Waud Capital Partners continues to identify and develop healthcare services platforms that address market fragmentation, operational inefficiencies, and patient care requirements. The firm’s team of nearly 70 professionals provides the institutional capabilities necessary to compete for the largest healthcare services opportunities while maintaining the partnership focus that has characterized Reeve Waud’s approach since the firm’s founding.
Bill Mixon’s partnership demonstrates the latest chapter in Waud Capital Partners’ healthcare services investment advancement, building on 30 years of systematic platform development, executive partnership, and comprehensive operational support to create sustained competitive advantages in healthcare private equity.
Continue: Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon
